News
Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of ...
The shipments have vaulted Ireland, a country of only five million people, into the second-largest goods-trade imbalance with ...
A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...
If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking ...
Gone are the days of battling obesity with a limited toolbox. With more weight loss supplements and drugs on the market than ever before, deciding which medication is right for you isn' ...
A radical shifting of trade flows has given Ireland the second-biggest trade imbalance with the U.S. after China, mostly due to demand for weight-loss drugs.
4h
Zacks.com on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?LLY's blockbuster obesity drugs fuel rapid growth but ABBV's valuation and pipeline may offer safer short-term upside.
For patients with obesity, clinicians should move beyond a "try and fail" approach to lifestyle interventions and prioritize ...
Investing.com -- The American College of Cardiology released new recommendations on Friday stating that millions more ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
It has been found in a phase I study that patients taking Eli Lilly's investigational obesity drug eloralintide lost more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results